Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation
Overall prescribing trends The study found that 2,855,602 patients were prescribed a GLP-1 RA between January 2019 and March 2026, with 14,738,765 total prescriptions during this period
Early research suggests it may influence certain biological repair pathways
When your GLP-1 signal is weak, you may feel hungry again quickly, even after a big meal, and it can feel like you need extra willpower just to eat normally
This is especially relevant during the early weeks of treatment when eating habits are changing, and appetite suppression tends to be most pronounced
The results are tracked against that baseline throughout the protocol